These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1550185)

  • 1. Ultramicrosurgical removal of subretinal hemorrhage in cats.
    Toth CA; Benner JD; Hjelmeland LM; Landers MB; Morse LS
    Am J Ophthalmol; 1992 Feb; 113(2):175-82. PubMed ID: 1550185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration.
    Benner JD; Hay A; Landers MB; Hjelmeland LM; Morse LS
    Ophthalmology; 1994 Apr; 101(4):672-81. PubMed ID: 8152762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage.
    Johnson MW; Olsen KR; Hernandez E
    Ophthalmology; 1992 Apr; 99(4):515-21. PubMed ID: 1584568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin directs early retinal damage after experimental subretinal hemorrhage.
    Toth CA; Morse LS; Hjelmeland LM; Landers MB
    Arch Ophthalmol; 1991 May; 109(5):723-9. PubMed ID: 2025175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.
    Peyman GA; Nelson NC; Alturki W; Blinder KJ; Paris CL; Desai UR; Harper CA
    Ophthalmic Surg; 1991 Oct; 22(10):575-82. PubMed ID: 1961614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
    Lewis H; Resnick SC; Flannery JG; Straatsma BR
    Am J Ophthalmol; 1991 Feb; 111(2):197-204. PubMed ID: 1899537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
    Johnson MW; Olsen KR; Hernandez E
    Retina; 1991; 11(2):250-8. PubMed ID: 1925092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
    Kamei M; Misono K; Lewis H
    Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration.
    Hesse L; Meitinger D; Schmidt J
    Ger J Ophthalmol; 1996 Nov; 5(6):479-83. PubMed ID: 9479539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat.
    Benner JD; Morse LS; Toth CA; Landers MB; Hjelmeland LM
    Arch Ophthalmol; 1991 Dec; 109(12):1731-6. PubMed ID: 1841586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis of experimental subretinal haemorrhage without removal using tissue plasminogen activator.
    Morse LS; Benner JD; Hjelmeland LM; Landers MB
    Br J Ophthalmol; 1996 Jul; 80(7):658-62. PubMed ID: 8795382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage.
    Saika S; Yamanaka A; Yamanaka A; Minamide A; Kin K; Shirai K; Tanaka S; Kawashima Y; Katoh T; Okada Y; Ohkawa K; Ohnishi Y
    Graefes Arch Clin Exp Ophthalmol; 1998 Mar; 236(3):196-201. PubMed ID: 9541823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model.
    Boone DE; Boldt HC; Ross RD; Folk JC; Kimura AE
    Retina; 1996; 16(6):518-24. PubMed ID: 9002136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subretinal hemorrhage removal with multiple retinotomy sites in age-related macular degeneration.
    Millsap CM; Peyman GA; Greve MD
    Ophthalmic Surg; 1994; 25(10):723-5. PubMed ID: 7898868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
    Coll GE; Sparrow JR; Marinovic A; Chang S
    Retina; 1995; 15(4):319-26. PubMed ID: 8545578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT; Sjaarda RN
    Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of subretinal hemorrhage.
    Hochman MA; Seery CM; Zarbin MA
    Surv Ophthalmol; 1997; 42(3):195-213. PubMed ID: 9406367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid.
    Kamei M; Tano Y; Maeno T; Ikuno Y; Mitsuda H; Yuasa T
    Am J Ophthalmol; 1996 Mar; 121(3):267-75. PubMed ID: 8597269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy.
    Vander JF
    Ophthalmic Surg; 1992 May; 23(5):361-3. PubMed ID: 1603542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.